Industry benchmark SPDR S&P Biotech ETF (XBI ... “After 3 years of painful underperformance, winter is finally thawing and spring just might be in the air,” Kasimov and the team wrote ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

"After biotech's record financial harvest over the last two years, the inevitable IPO winter has arrived, and there are numerous signs that public capital is becoming more scarce – hopefully on ...

Laura Varley is a Careers reporter at Silicon Republic. She has a background in technology PR and journalism and is borderline obsessed with film and television, the theatre, Marvel and Mayo GAA ...

Santa Cruz Biotechnology, Inc. (SCBT), one of the world’s largest suppliers of antibodies derived from the blood of animals (goats and rabbits), has been cited by USDA veterinary inspectors for ...

In his keynote speech celebrating the discovery of the DNA double helix at last month's Miami Nature Biotechnology Winter Symposium, Jim Watson referred to DNA as “the script” and proteins as ...